Trials / Completed
CompletedNCT05966974
GRACE - Study of AGN1 LOEP in Osteopenic and Osteoporotic Patients
Study of Elective AGN1 LOEP in Osteopenic and Osteoporotic Subjects - a Retrospective Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- AgNovos Healthcare, LLC · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study is designed as a retrospective, single-center study for subjects previously treated with the AGN1 LOEP Kit. This will be a non-randomized and non-blinded study. The study will collect retrospective data on the safety and performance of AGN1 LOEP of all subjects treated outside of any other clinical study protocols between September 2019 and November 2022. A prospective questionnaire will be included to evaluate self-reported subject experiences.
Conditions
Timeline
- Start date
- 2022-12-15
- Primary completion
- 2023-04-03
- Completion
- 2023-04-03
- First posted
- 2023-08-01
- Last updated
- 2023-08-01
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05966974. Inclusion in this directory is not an endorsement.